Yahoo Finance • 4 days ago
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the Company), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that the... Full story
Yahoo Finance • 16 days ago
PHILADELPHIA, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) – Class Action Reaches Settlement: Grabar Law Office is investigating claims on behalf of shareholders of Applied Therapeutics. The investigatio... Full story
Yahoo Finance • 18 days ago
PHILADELPHIA, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics (NASDAQ: APLT) – Class Action Reaches Settlement: Grabar Law Office is investigating claims on behalf of shareholders of Applied Therapeutics. The investigation conc... Full story
Yahoo Finance • 21 days ago
PHILADELPHIA, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics (NASDAQ: APLT) – Class Action Reaches Settlement: Grabar Law Office is investigating claims on behalf of shareholders of Applied Therapeutics. The investigation conc... Full story
Yahoo Finance • 22 days ago
PHILADELPHIA, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics (NASDAQ: APLT) – Class Action Reaches Settlement: A securities fraud class action against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of its officers has r... Full story
Yahoo Finance • 23 days ago
PHILADELPHIA, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics (NASDAQ: APLT) – Class Action Reaches Settlement: Grabar Law Office is investigating claims on behalf of shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). T... Full story
Yahoo Finance • 2 months ago
* Applied Therapeutics press release [https://seekingalpha.com/pr/20200354-applied-therapeutics-reports-second-quarter-2025-financial-results] (NASDAQ:APLT [https://seekingalpha.com/symbol/APLT]): Q2 GAAP EPS of -$0.15 beats by $0.01.... Full story
Yahoo Finance • 2 months ago
- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD - Presented full 12-month clinical results and new topline data from INSPIRE Phase 2/3 trial of govorestat for the... Full story
Yahoo Finance • 4 months ago
NEW YORK - Applied Therapeutics, Inc. (NASDAQ:APLT), a biopharmaceutical company with a market capitalization of approximately $50 million, announced on Tuesday the promotion of Evan Bailey, MD, to Chief Medical Officer and Dottie Caplan t... Full story
Yahoo Finance • 4 months ago
Evan Bailey, MD, promoted to Chief Medical Officer, succeeding Riccardo Perfetti, MD, PhDDottie Caplan promoted to Executive Vice President, Patient Advocacy and Government Affairs NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Applied The... Full story
Yahoo Finance • 5 months ago
Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through 24 months Statistically significant correlation between absolute reduction in sorbitol and change in 10... Full story
Yahoo Finance • 5 months ago
- Company to present full 12-month clinical data and new topline 18-month and 24-month data from INSPIRE registrational Phase 3 trial of govorestat in CMT-SORD Deficiency at the Peripheral Nerve Society 2025 Annual Meeting - Review of gov... Full story
Yahoo Finance • 5 months ago
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises NET Power Inc. ("NET Power " or the "Company") (NASDAQ: APLT) investo... Full story
Yahoo Finance • 6 months ago
- Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot as Vice President and Head of Quality NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Applied Therapeuti... Full story
Yahoo Finance • 6 months ago
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indi... Full story
Yahoo Finance • 7 months ago
NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The laws... Full story
Yahoo Finance • 7 months ago
LOS ANGELES, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story
Yahoo Finance • 7 months ago
NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company’s senior executives f... Full story
Yahoo Finance • 7 months ago
NEW YORK, Feb. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates i... Full story
Yahoo Finance • 8 months ago
NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company’s senior executives f... Full story